ZNF17
gene geneOn this page
Also known as HPF3KOX10KIAA1947FLJ40864FLJ46058FLJ46615
Summary
ZNF17 (zinc finger protein 17, HGNC:12958) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 17 (P17021). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 7565 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 96 total
- MANE Select transcript:
NM_001330617
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12958 |
| Approved symbol | ZNF17 |
| Name | zinc finger protein 17 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HPF3, KOX10, KIAA1947, FLJ40864, FLJ46058, FLJ46615 |
| Ensembl gene | ENSG00000186272 |
| Ensembl biotype | protein_coding |
| OMIM | 619254 |
| Entrez | 7565 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 6 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000307658, ENST00000595162, ENST00000595206, ENST00000597350, ENST00000599867, ENST00000601808, ENST00000602050, ENST00000878542, ENST00000964805, ENST00000964806
RefSeq mRNA: 2 — MANE Select: NM_001330617
NM_001330617, NM_006959
CCDS: CCDS42636, CCDS82405
Canonical transcript exons
ENST00000307658 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001170822 | 57419635 | 57421934 |
| ENSE00003160959 | 57411161 | 57411406 |
| ENSE00003686570 | 57413596 | 57413636 |
| ENSE00003784919 | 57417912 | 57418038 |
Expression profiles
Bgee: expression breadth ubiquitous, 136 present calls, max score 85.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9803 / max 50.1750, expressed in 1507 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177772 | 3.9803 | 1507 |
Top tissues by expression
136 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.68 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.64 | gold quality |
| corpus callosum | UBERON:0002336 | 80.34 | gold quality |
| ventricular zone | UBERON:0003053 | 79.26 | gold quality |
| cortical plate | UBERON:0005343 | 79.26 | gold quality |
| calcaneal tendon | UBERON:0003701 | 77.98 | gold quality |
| embryo | UBERON:0000922 | 77.73 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.73 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 77.12 | gold quality |
| tonsil | UBERON:0002372 | 76.84 | gold quality |
| endometrium | UBERON:0001295 | 76.00 | gold quality |
| muscle tissue | UBERON:0002385 | 75.86 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 75.75 | gold quality |
| skeletal muscle organ | UBERON:0014892 | 75.48 | gold quality |
| muscle of leg | UBERON:0001383 | 75.42 | gold quality |
| gastrocnemius | UBERON:0001388 | 75.23 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 75.18 | gold quality |
| apex of heart | UBERON:0002098 | 75.12 | gold quality |
| islet of Langerhans | UBERON:0000006 | 74.89 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.67 | gold quality |
| urinary bladder | UBERON:0001255 | 74.66 | gold quality |
| granulocyte | CL:0000094 | 74.65 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.17 | gold quality |
| ovary | UBERON:0000992 | 74.09 | gold quality |
| lymph node | UBERON:0000029 | 73.98 | gold quality |
| heart left ventricle | UBERON:0002084 | 73.98 | gold quality |
| heart | UBERON:0000948 | 73.91 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.83 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 73.81 | gold quality |
| left ovary | UBERON:0002119 | 73.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.58 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting ZNF17, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-32-5P | 99.98 | 75.21 | 1964 |
| HSA-MIR-363-3P | 99.98 | 74.72 | 1821 |
| HSA-MIR-367-3P | 99.98 | 74.83 | 1819 |
| HSA-MIR-92A-3P | 99.98 | 75.21 | 1960 |
| HSA-MIR-92B-3P | 99.98 | 75.25 | 1955 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-8087 | 99.90 | 69.55 | 1351 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-302B-5P | 99.50 | 69.49 | 1857 |
| HSA-MIR-302D-5P | 99.50 | 69.34 | 1863 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-6505-3P | 99.34 | 67.39 | 1071 |
| HSA-MIR-4777-5P | 99.33 | 67.53 | 1148 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-449B-3P | 99.20 | 67.24 | 1047 |
| HSA-MIR-1257 | 98.97 | 68.02 | 1133 |
| HSA-MIR-4742-3P | 98.73 | 69.82 | 1803 |
| HSA-MIR-4317 | 98.49 | 67.09 | 987 |
| HSA-MIR-1912-5P | 97.94 | 67.98 | 832 |
| HSA-MIR-630 | 97.50 | 66.38 | 921 |
| HSA-MIR-6831-3P | 97.49 | 69.29 | 505 |
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 17 — P17021 (reviewed: P17021)
Alternative names: Zinc finger protein HPF3, Zinc finger protein KOX10
All UniProt accessions (3): P17021, M0QZR3, M0R2T2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P17021-1 | 1 | yes |
| P17021-2 | 2 | |
| P17021-3 | 3 |
RefSeq proteins (2): NP_001317546, NP_008890 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (24 total): zinc finger region 16, sequence conflict 3, splice variant 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P17021-F1 | 73.17 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 37 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ACACTGG_MIR199A_MIR199B, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, DLX4_TARGET_GENES, MIR10527_5P, MIR497_3P, MIR302B_5P, MIR302D_5P, MIR329_5P, MIR1257, MIR449B_3P, MIR630, MIR6831_3P, SMN1_SMN2_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
580 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF17 | OR10G2 | Q8NGC3 | 447 |
| ZNF17 | EFCAB8 | A8MWE9 | 396 |
| ZNF17 | C5orf15 | Q8NC54 | 395 |
| ZNF17 | ABHD1 | Q96SE0 | 311 |
| ZNF17 | MAMDC4 | Q6UXC1 | 306 |
| ZNF17 | SPAG17 | Q6Q759 | 291 |
| ZNF17 | CEP20 | Q96NB1 | 290 |
| ZNF17 | TMCC1 | O94876 | 276 |
| ZNF17 | SVIL | O95425 | 272 |
| ZNF17 | HOGA1 | Q86XE5 | 261 |
| ZNF17 | CORO2B | Q9UQ03 | 256 |
| ZNF17 | UNC79 | Q9P2D8 | 254 |
| ZNF17 | GPR107 | Q5VW38 | 252 |
| ZNF17 | FAM111B | Q6SJ93 | 248 |
| ZNF17 | SLC26A11 | Q86WA9 | 247 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF17 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | OPTN | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | ZRANB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | SET | psi-mi:“MI:0915”(physical association) | 0.560 |
| YJU2B | ZNF17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | AIRIM | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF17 | ZNF438 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF17 | TRIM24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF17 | NDEL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NDEL1 | ZNF17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | ZNF837 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | GOLGA6L9 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | OPTN | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | ZRANB1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.000 |
| AIRIM | ZNF17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SET | ZNF17 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF17 | YJU2B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (38): ZNF17 (Synthetic Growth Defect), ZNF17 (Affinity Capture-RNA), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), ZNF17 (Two-hybrid), GOLGA6L9 (Two-hybrid), KRT40 (Two-hybrid), DAP3 (Affinity Capture-MS)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, B2RUI1, O43296, O75123, P10072, P17020, P17021, P17097, P51814, P52740, P52741, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8TAU3
Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
96 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 84 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
866 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57418035:GTAG:G | donor_gain | 1.0000 |
| 19:57411402:CTGAG:C | donor_loss | 0.9900 |
| 19:57411403:TGAG:T | donor_loss | 0.9900 |
| 19:57411405:AGGTG:A | donor_loss | 0.9900 |
| 19:57411407:G:GA | donor_loss | 0.9900 |
| 19:57411408:T:G | donor_loss | 0.9900 |
| 19:57411006:C:T | donor_gain | 0.9800 |
| 19:57411015:T:G | donor_gain | 0.9800 |
| 19:57411015:T:TG | donor_gain | 0.9800 |
| 19:57411010:T:G | donor_gain | 0.9700 |
| 19:57417911:GGATT:G | acceptor_gain | 0.9700 |
| 19:57418034:AGTAG:A | donor_loss | 0.9700 |
| 19:57418037:AG:A | donor_loss | 0.9700 |
| 19:57418038:GGTAA:G | donor_loss | 0.9700 |
| 19:57418039:GTAA:G | donor_loss | 0.9700 |
| 19:57418040:T:G | donor_loss | 0.9700 |
| 19:57419634:GGTT:G | acceptor_gain | 0.9700 |
| 19:57411409:GGGT:G | donor_loss | 0.9600 |
| 19:57411410:GGTG:G | donor_loss | 0.9600 |
| 19:57417910:A:AG | acceptor_gain | 0.9600 |
| 19:57417910:AG:A | acceptor_gain | 0.9600 |
| 19:57417911:G:GG | acceptor_gain | 0.9600 |
| 19:57417911:GG:G | acceptor_gain | 0.9600 |
| 19:57419628:GTTTT:G | acceptor_loss | 0.9600 |
| 19:57419629:TTTTA:T | acceptor_loss | 0.9600 |
| 19:57419630:TTTA:T | acceptor_loss | 0.9600 |
| 19:57419631:TTA:T | acceptor_loss | 0.9600 |
| 19:57419631:TTAG:T | acceptor_loss | 0.9600 |
| 19:57419632:TA:T | acceptor_loss | 0.9600 |
| 19:57419633:A:AC | acceptor_loss | 0.9600 |
AlphaMissense
4492 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57421011:T:C | F507L | 0.994 |
| 19:57421013:T:A | F507L | 0.994 |
| 19:57421013:T:G | F507L | 0.994 |
| 19:57421431:T:C | F647L | 0.994 |
| 19:57421433:T:A | F647L | 0.994 |
| 19:57421433:T:G | F647L | 0.994 |
| 19:57420423:T:C | F311L | 0.993 |
| 19:57420425:C:A | F311L | 0.993 |
| 19:57420425:C:G | F311L | 0.993 |
| 19:57420790:A:C | Q433P | 0.991 |
| 19:57421347:T:C | F619L | 0.991 |
| 19:57421349:T:A | F619L | 0.991 |
| 19:57421349:T:G | F619L | 0.991 |
| 19:57420255:T:C | F255L | 0.990 |
| 19:57420257:C:A | F255L | 0.990 |
| 19:57420257:C:G | F255L | 0.990 |
| 19:57420786:C:G | H432D | 0.990 |
| 19:57420956:T:A | H488Q | 0.990 |
| 19:57420956:T:G | H488Q | 0.990 |
| 19:57420958:A:C | Q489P | 0.990 |
| 19:57420339:T:C | F283L | 0.989 |
| 19:57420341:T:A | F283L | 0.989 |
| 19:57420341:T:G | F283L | 0.989 |
| 19:57420538:A:C | Q349P | 0.989 |
| 19:57420954:C:G | H488D | 0.989 |
| 19:57420507:T:C | F339L | 0.988 |
| 19:57420509:T:A | F339L | 0.988 |
| 19:57420509:T:G | F339L | 0.988 |
| 19:57420704:T:A | H404Q | 0.988 |
| 19:57420704:T:G | H404Q | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000400318 (19:57414190 T>C), RS1000755043 (19:57412442 TAA>T), RS1000774038 (19:57419703 G>A), RS1001003663 (19:57413918 A>T), RS1001170822 (19:57417279 G>A,C), RS1001280690 (19:57411241 C>A,T), RS1001363243 (19:57418445 T>A), RS1001449104 (19:57416920 G>A), RS1002187054 (19:57417796 G>A,C), RS1002275343 (19:57412414 C>G,T), RS1002480799 (19:57412660 G>A), RS1002645763 (19:57417449 A>G), RS1002732895 (19:57410178 A>G), RS1002966800 (19:57421634 C>A,T), RS1003123889 (19:57415517 G>A)
Disease associations
OMIM: gene MIM:619254 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression, affects cotreatment | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| manganese chloride | increases abundance, increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| bisphenol S | affects cotreatment, increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Manganese | increases abundance, increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Urethane | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.